HLA-E: A Novel Player for Histocompatibility

WorldwideHLA-Enucleotide and haplotype variability reveals a conserved gene for coding and 3′ untranslated regions

(2014) L. P. Felício et al.   TISSUE ANTIGENS

MicroRNA Editing Facilitates Immune Elimination of HCMV Infected Cells

(2014) Daphna Nachmani et al.   PLoS Pathogens

Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells

(2013) A. M. Merino et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility

(2013) Xue Zeng et al.   EXPERIMENTAL DERMATOLOGY

Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells

(2013) Susan L. Heatley et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Large Spectrum of HLA-C Recognition by Killer Ig-like Receptor (KIR)2DL2 and KIR2DL3 and Restricted C1 Specificity of KIR2DS2: Dominant Impact of KIR2DL2/KIR2DS2 on KIR2D NK Cell Repertoire Formation

(2013) G. David et al.   JOURNAL OF IMMUNOLOGY

Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09

(2012) Trevor Huyton et al.   IMMUNOGENETICS

Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2

(2012) Margit H. Lampen et al.   MOLECULAR IMMUNOLOGY

HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation

(2012) Mathilde Allard et al.   PLoS One

HLA-E polymorphisms in hematopoietic stem cell transplantation

(2012) D. Fürst et al.   TISSUE ANTIGENS

Pocketcheck: updating the HLA class I peptide specificity roadmap

(2012) T. Huyton et al.   TISSUE ANTIGENS

Non-classical MHC-Ι genes in chronic hepatitis B and hepatocellular carcinoma

(2011) Jian Zhang et al.   IMMUNOGENETICS

HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression

(2011) Céline Bossard et al.   INTERNATIONAL JOURNAL OF CANCER

Human Cytomegalovirus Disrupts the Major Histocompatibility Complex Class I Peptide-Loading Complex and Inhibits Tapasin Gene Transcription

(2011) A. Halenius et al.   JOURNAL OF VIROLOGY

HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

(2011) M. Gooden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family

(2010) C. Bade-Doding et al.   HAEMATOLOGICA

Activating and inhibitory receptors of natural killer cells

(2010) Hollie J Pegram et al.   IMMUNOLOGY AND CELL BIOLOGY

HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

(2010) E. M. de Kruijf et al.   JOURNAL OF IMMUNOLOGY

Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5

(2009) M. Sensi et al.   INTERNATIONAL IMMUNOLOGY

Association of HLA-E Polymorphism With the Outcome of Hematopoietic Stem-Cell Transplantation With Unrelated Donors

(2009) Katarina Ludajic et al.   TRANSPLANTATION

Clinical Significance of HLA-E*0103 Homozygosity on Survival After Allogeneic Hematopoietic Stem-Cell Transplantation

(2009) Martin Danzer et al.   TRANSPLANTATION

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

(2008) Emma J. Petrie et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94–NKG2 Natural Killer Cell Receptors

(2008) Hilary L. Hoare et al.   JOURNAL OF MOLECULAR BIOLOGY

Structural basis for NKG2A/CD94 recognition of HLA-E

(2008) B. K. Kaiser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA